Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dachengqi Decoction for GI Recovery After Whipple Surgery
NCT06948474Active, not recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Aug 2024
- Primary completion
- Mar 2026
- Modality
- Traditional Chinese Medicine Formula
- Countries
- 1
01
Overview
Randomised, open-label trial of Dachengqi Decoction in Postoperative gastrointestinal dysfunction (POGD) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Gastrointestinal Function Evaluation at 1 month and Patient-Generated Subjective Global Assessment Score at 1 month. Started Aug 2024; status: active, not recruiting.
02
Drugs
Dachengqi Decoction
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on NCT06948474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06948474.